Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea (Q36875372)
Jump to navigation
Jump to search
scientific article published on 17 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea |
scientific article published on 17 May 2010 |
Statements
1 reference
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea (English)
1 reference
Beverly Moy
1 reference
Eric Winer
1 reference
Nancy Lin
1 reference
Alyson Abbruzzi
1 reference
Steven Sugarman
1 reference
Richard Steingart
1 reference
Chau Dang
1 reference
Steven Come
1 reference
Patrick Morris
1 reference
Carol Chen
1 reference
Sujata Patil
1 reference
Clifford Hudis
1 reference
17 May 2010
1 reference
1 reference
2982-2988
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference